Capital Advisors Ltd’s Halozyme HALO Stock Holding History

Capital Advisors Ltd’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Hold	12	–	–	﹤0.01%	1236
2026 Q1	$1K	Hold	12	–	–	﹤0.01%	1224
2025 Q4	$1K	Hold	12	–	–	﹤0.01%	1203
2025 Q3	$1K	Hold	12	–	–	﹤0.01%	1202
2025 Q2	$1K	Hold	12	–	–	﹤0.01%	1195
2025 Q1	$1K	Hold	12	–	–	﹤0.01%	1187
2024 Q4	$1K	Hold	12	–	–	﹤0.01%	1212
2024 Q3	$1K	Hold	12	–	–	﹤0.01%	1211
2024 Q2	$1K	Buy	+12	New	+$526	﹤0.01%	1203
2023 Q2	–	Sell	-1	Closed	–	–	1393
2023 Q1	$0	Sell	1 -11	-92%	-$516	﹤0.01%	1343
2022 Q4	$1K	Hold	12	–	–	﹤0.01%	1005
2022 Q3	$0	Hold	12	–	–	﹤0.01%	1336
2022 Q2	$1K	Hold	12	–	–	﹤0.01%	792
2022 Q1	$0	Buy	+12	New	+$427	﹤0.01%	1031

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Capital Advisors Ltd's HALO Position: Q2 2026 in Review

Capital Advisors Ltd held its Halozyme (HALO) position steady in Q2 2026 at 12 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

Capital Advisors Ltd first reported a position in HALO in Q1 2022 and has held it in 14 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Capital Advisors Ltd held 12 shares of Halozyme worth $1K as of Q2 2026.
Capital Advisors Ltd left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1236 holding.
Capital Advisors Ltd first reported a position in Halozyme in Q1 2022 and has held it in 14 quarters since.
668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.